| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |